B4
Thomas White Oxford Ltd, the development company of St John’s College, has agreed a 50:50 joint venture partnership with Canadian-based Cadillac Fairview, the real estate arm of Ontario Teachers’ Pension Plan, with developer Stanhope PLC, to deliver Oxford North, Oxford, UK, the £700 million new global innovation district.
The corporate team at Penningtons Manches Cooper has advised Oxford University spin-out Orthox Limited on the completion of a further $4.3 million (£3.2 million) to close its $12.5 million (£9.2 million) Series A financing round.
Owen Mumford, a global leader in the design, manufacture and advancement of medical devices, has announced its emissions reduction targets through the Science Based Targets initiative (SBTi). The company has set a target to achieve net zero by 2045 (to mirror the UK NHS target) in alignment with the recommendations of the 2015 Paris Agreement.
The global healthcare system is a large contributor to greenhouse gas emissions, representing 4.4% of the total worldwide footprint.¹ Supply chains occupy a significant share of this contribution. In the UK, for instance, 62% of the National Health Service’s emissions footprint came from the supply chain in 2019.²
The Penningtons Manches Cooper corporate team has advised the shareholders of ATDBio on its sale to NASDAQ Stockholm listed Biotage AB. The purchase price was approximately £45m on a debt free and cash free basis. ATDBio was founded in 2005 by Professor Tom Brown (Snr), one of the world’s leading nucleic acids chemists, Dr Dorcas […]
EquiTrace, a unique app for horses that combines identity, GPS and medical records data using a scanner, a microchip and a mobile phone, has signed an investment agreement with a syndicate of HBAN angel investors led by Brendan Nevin, CEO of Code Institute for 1million euros. Enterprise Ireland will also be investing in the company, providing 250,000 euros. EquiTrace will use the investment to grow the company, building a sales and development team as well as investing in marketing, and focus on global expansion.
Industry first single-use auto-injector for both 1ml and 2.25 pre-filled syringes with versatile design for different fill volumes in the same device.
The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to commence the second phase of its conversion of dedicated high spec laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, following £0.2 million additional Local Growth Fund support, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).
Biotech start-up, DJS Antibodies, is the second company to move into the newly converted class II laboratory space at The Oxford Trust’s Wood Centre for Innovation.
The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to undertake a half million-pound project to install life science laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, to increase capacity for the local innovation ecosystem and has received £0.1 million in funding towards the project via the Government’s Local Growth Fund, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).